Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Hairy Cell | 3 | 2017 | 82 | 1.510 |
Why?
|
Lymphoma, T-Cell | 6 | 2024 | 305 | 1.210 |
Why?
|
Myeloproliferative Disorders | 7 | 2023 | 609 | 1.040 |
Why?
|
Leukemia, Myeloid, Acute | 15 | 2023 | 3602 | 1.030 |
Why?
|
Integrin alpha Chains | 2 | 2014 | 95 | 0.880 |
Why?
|
Myelodysplastic Syndromes | 7 | 2023 | 1394 | 0.860 |
Why?
|
Plasmacytoma | 1 | 2019 | 171 | 0.630 |
Why?
|
Skin Neoplasms | 9 | 2023 | 5799 | 0.620 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2020 | 727 | 0.600 |
Why?
|
Dendritic Cells | 6 | 2023 | 2725 | 0.600 |
Why?
|
Mastocytosis | 1 | 2020 | 149 | 0.580 |
Why?
|
Hematologic Neoplasms | 4 | 2023 | 1895 | 0.520 |
Why?
|
Enteropathy-Associated T-Cell Lymphoma | 1 | 2014 | 13 | 0.490 |
Why?
|
Leukemia, T-Cell | 1 | 2014 | 101 | 0.470 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2016 | 331 | 0.470 |
Why?
|
Lymphoma, B-Cell | 3 | 2019 | 935 | 0.470 |
Why?
|
Integrin beta3 | 2 | 2016 | 121 | 0.460 |
Why?
|
Antigens, CD | 2 | 2014 | 4000 | 0.430 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2019 | 547 | 0.430 |
Why?
|
Lymph Nodes | 5 | 2023 | 3486 | 0.410 |
Why?
|
Lymphoma, Mantle-Cell | 3 | 2023 | 237 | 0.410 |
Why?
|
Immunophenotyping | 8 | 2019 | 1871 | 0.410 |
Why?
|
Paired Box Transcription Factors | 1 | 2012 | 207 | 0.400 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 3 | 2019 | 167 | 0.390 |
Why?
|
Hemangiosarcoma | 2 | 2019 | 216 | 0.380 |
Why?
|
Lymphoma | 5 | 2022 | 1898 | 0.370 |
Why?
|
Micrococcaceae | 1 | 2010 | 8 | 0.360 |
Why?
|
Bone Resorption | 4 | 2010 | 720 | 0.340 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1705 | 0.340 |
Why?
|
Sarcoma, Myeloid | 2 | 2023 | 51 | 0.330 |
Why?
|
Neoplasms, Second Primary | 2 | 2017 | 1056 | 0.310 |
Why?
|
Bone Marrow | 7 | 2023 | 2912 | 0.310 |
Why?
|
Dermatitis | 1 | 2010 | 200 | 0.300 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2020 | 209 | 0.290 |
Why?
|
Mutation | 18 | 2023 | 29932 | 0.290 |
Why?
|
Langerhans Cells | 2 | 2018 | 171 | 0.290 |
Why?
|
Hemostasis | 1 | 2009 | 468 | 0.280 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 951 | 0.280 |
Why?
|
Mutation, Missense | 1 | 2016 | 2566 | 0.280 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 264 | 0.270 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 2 | 2018 | 45 | 0.260 |
Why?
|
Lymphoproliferative Disorders | 3 | 2020 | 533 | 0.260 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2020 | 381 | 0.260 |
Why?
|
Receptors, Immunologic | 2 | 2024 | 1411 | 0.260 |
Why?
|
Translocation, Genetic | 3 | 2021 | 1388 | 0.260 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2023 | 2828 | 0.250 |
Why?
|
Receptors, CXCR4 | 5 | 2020 | 728 | 0.250 |
Why?
|
Histiocytosis, Langerhans-Cell | 2 | 2017 | 169 | 0.240 |
Why?
|
Immunohistochemistry | 13 | 2020 | 11071 | 0.240 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3616 | 0.240 |
Why?
|
Lymphoma, Follicular | 2 | 2021 | 453 | 0.240 |
Why?
|
Antibodies, Monoclonal | 7 | 2024 | 9185 | 0.230 |
Why?
|
Genes, Mating Type, Fungal | 2 | 2002 | 25 | 0.220 |
Why?
|
Bacteremia | 1 | 2010 | 980 | 0.210 |
Why?
|
Waldenstrom Macroglobulinemia | 3 | 2020 | 1067 | 0.210 |
Why?
|
Breast Implants | 2 | 2018 | 410 | 0.210 |
Why?
|
Paraffin Embedding | 2 | 2014 | 302 | 0.210 |
Why?
|
Core Binding Factors | 2 | 2021 | 29 | 0.210 |
Why?
|
Skin | 4 | 2023 | 4466 | 0.200 |
Why?
|
Genes, Fungal | 2 | 2002 | 439 | 0.200 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2024 | 3584 | 0.200 |
Why?
|
Hodgkin Disease | 3 | 2018 | 1378 | 0.190 |
Why?
|
Dog Diseases | 1 | 2022 | 141 | 0.190 |
Why?
|
Nuclear Proteins | 6 | 2023 | 5791 | 0.190 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2020 | 42 | 0.180 |
Why?
|
Lectins, C-Type | 1 | 2024 | 587 | 0.180 |
Why?
|
Rwanda | 2 | 2021 | 659 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2019 | 2919 | 0.180 |
Why?
|
Humans | 77 | 2024 | 760621 | 0.170 |
Why?
|
Cyclophosphamide | 3 | 2022 | 2221 | 0.170 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2023 | 321 | 0.170 |
Why?
|
Wills | 1 | 2019 | 13 | 0.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2023 | 5649 | 0.160 |
Why?
|
Cyclin D1 | 2 | 2019 | 451 | 0.160 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 223 | 0.160 |
Why?
|
Colic | 1 | 2019 | 44 | 0.160 |
Why?
|
Pancytopenia | 1 | 2019 | 101 | 0.160 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 372 | 0.160 |
Why?
|
Alkylating Agents | 1 | 2019 | 133 | 0.160 |
Why?
|
Blood Platelets | 1 | 2009 | 2520 | 0.160 |
Why?
|
Leukemic Infiltration | 1 | 2018 | 47 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2018 | 368 | 0.160 |
Why?
|
Fungal Proteins | 1 | 2002 | 911 | 0.150 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1078 | 0.150 |
Why?
|
Macrophages | 4 | 2019 | 5745 | 0.150 |
Why?
|
Histiocytes | 1 | 2018 | 98 | 0.150 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2018 | 228 | 0.150 |
Why?
|
Schistosomiasis mansoni | 1 | 2018 | 94 | 0.150 |
Why?
|
Blood Cells | 1 | 2019 | 305 | 0.150 |
Why?
|
Schistosoma mansoni | 1 | 2018 | 156 | 0.150 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2018 | 92 | 0.150 |
Why?
|
Precursor Cells, T-Lymphoid | 1 | 2017 | 19 | 0.150 |
Why?
|
Prognosis | 10 | 2023 | 29658 | 0.140 |
Why?
|
Aged, 80 and over | 18 | 2021 | 58995 | 0.140 |
Why?
|
Bone Neoplasms | 5 | 2015 | 2532 | 0.140 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2018 | 452 | 0.140 |
Why?
|
GATA3 Transcription Factor | 1 | 2017 | 152 | 0.140 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 911 | 0.140 |
Why?
|
Middle Aged | 31 | 2021 | 220352 | 0.140 |
Why?
|
Receptors, IgG | 1 | 2019 | 559 | 0.130 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2016 | 53 | 0.130 |
Why?
|
Histone Demethylases | 1 | 2019 | 323 | 0.130 |
Why?
|
Adenosine Triphosphate | 1 | 2002 | 1993 | 0.130 |
Why?
|
Histiocytic Necrotizing Lymphadenitis | 1 | 2016 | 26 | 0.130 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2002 | 1854 | 0.130 |
Why?
|
Histiocytosis, Sinus | 1 | 2016 | 46 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2021 | 1075 | 0.130 |
Why?
|
Male | 40 | 2021 | 359744 | 0.130 |
Why?
|
Aged | 29 | 2021 | 169152 | 0.130 |
Why?
|
Genetic Testing | 3 | 2019 | 3531 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 727 | 0.130 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2019 | 8515 | 0.120 |
Why?
|
Breast Implantation | 1 | 2018 | 223 | 0.120 |
Why?
|
DNA Repair | 2 | 2021 | 2039 | 0.120 |
Why?
|
Female | 39 | 2023 | 391270 | 0.120 |
Why?
|
Calreticulin | 1 | 2016 | 115 | 0.120 |
Why?
|
Cardiac Tamponade | 1 | 2016 | 174 | 0.120 |
Why?
|
Immunoglobulin M | 2 | 2017 | 1529 | 0.120 |
Why?
|
Breast Neoplasms | 6 | 2019 | 21025 | 0.120 |
Why?
|
Receptors, Thrombopoietin | 1 | 2016 | 161 | 0.120 |
Why?
|
Saccharomyces cerevisiae | 2 | 2002 | 2698 | 0.120 |
Why?
|
Quinazolinones | 1 | 2016 | 223 | 0.120 |
Why?
|
B-Lymphocytes | 3 | 2017 | 4742 | 0.120 |
Why?
|
Primary Myelofibrosis | 1 | 2016 | 210 | 0.110 |
Why?
|
Killer Cells, Natural | 2 | 2024 | 2203 | 0.110 |
Why?
|
Frozen Sections | 1 | 2014 | 153 | 0.110 |
Why?
|
Review Literature as Topic | 1 | 2016 | 349 | 0.110 |
Why?
|
Pathology, Clinical | 1 | 2017 | 375 | 0.110 |
Why?
|
Activated Protein C Resistance | 1 | 2013 | 18 | 0.110 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2018 | 581 | 0.110 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4107 | 0.110 |
Why?
|
Colonic Polyps | 1 | 2019 | 551 | 0.110 |
Why?
|
HLA Antigens | 1 | 2019 | 1368 | 0.110 |
Why?
|
Mice | 20 | 2024 | 81208 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 453 | 0.110 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2016 | 1628 | 0.110 |
Why?
|
Peroneal Nerve | 1 | 2013 | 76 | 0.110 |
Why?
|
Adult | 25 | 2023 | 219994 | 0.110 |
Why?
|
Leg | 1 | 2018 | 1090 | 0.110 |
Why?
|
Factor V | 1 | 2013 | 168 | 0.110 |
Why?
|
Purines | 1 | 2016 | 605 | 0.100 |
Why?
|
Multiple Myeloma | 3 | 2017 | 5130 | 0.100 |
Why?
|
Polyarteritis Nodosa | 1 | 2013 | 70 | 0.100 |
Why?
|
Cell Line, Tumor | 7 | 2024 | 16939 | 0.100 |
Why?
|
Gene Deletion | 2 | 2019 | 2668 | 0.100 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2014 | 124 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1596 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2022 | 11712 | 0.100 |
Why?
|
Animals | 23 | 2024 | 167963 | 0.100 |
Why?
|
Cell Cycle Proteins | 2 | 2021 | 3446 | 0.100 |
Why?
|
Organ Specificity | 2 | 2023 | 1955 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 3 | 2020 | 4490 | 0.100 |
Why?
|
Clone Cells | 3 | 2023 | 1660 | 0.100 |
Why?
|
Pericardium | 1 | 2016 | 675 | 0.100 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2013 | 179 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1547 | 0.090 |
Why?
|
Leukemia | 2 | 2017 | 1520 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2018 | 938 | 0.090 |
Why?
|
Hematopoiesis | 2 | 2017 | 2050 | 0.090 |
Why?
|
Melanoma | 1 | 2009 | 5697 | 0.090 |
Why?
|
Gait Disorders, Neurologic | 1 | 2013 | 238 | 0.090 |
Why?
|
Antineoplastic Agents | 6 | 2018 | 13630 | 0.090 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2014 | 0.090 |
Why?
|
DNA-Binding Proteins | 4 | 2020 | 9585 | 0.090 |
Why?
|
Flow Cytometry | 2 | 2018 | 5870 | 0.090 |
Why?
|
Sarcoidosis | 1 | 2016 | 520 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 730 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2018 | 11481 | 0.090 |
Why?
|
Receptor, Notch1 | 1 | 2013 | 495 | 0.090 |
Why?
|
Actinomycetales Infections | 1 | 2010 | 30 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1837 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1190 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1407 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3928 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2019 | 3610 | 0.080 |
Why?
|
Biopsy | 4 | 2018 | 6771 | 0.080 |
Why?
|
Prednisolone | 2 | 2022 | 327 | 0.080 |
Why?
|
Predictive Value of Tests | 5 | 2018 | 15289 | 0.080 |
Why?
|
Repressor Proteins | 2 | 2017 | 2981 | 0.080 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2017 | 1375 | 0.080 |
Why?
|
Mice, SCID | 3 | 2021 | 2627 | 0.080 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2014 | 611 | 0.080 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1755 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1484 | 0.080 |
Why?
|
Survival Rate | 4 | 2019 | 12808 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2313 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2019 | 3758 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 1403 | 0.080 |
Why?
|
Vincristine | 2 | 2022 | 1039 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 2 | 2017 | 3387 | 0.070 |
Why?
|
Chemokine CXCL12 | 1 | 2010 | 454 | 0.070 |
Why?
|
Bone and Bones | 2 | 2017 | 2560 | 0.070 |
Why?
|
Hepatitis B | 1 | 2013 | 701 | 0.070 |
Why?
|
Sarcoma | 1 | 2019 | 1786 | 0.070 |
Why?
|
Mice, Mutant Strains | 2 | 2021 | 1753 | 0.070 |
Why?
|
Genomics | 2 | 2021 | 5794 | 0.070 |
Why?
|
Opportunistic Infections | 1 | 2010 | 377 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2016 | 2299 | 0.070 |
Why?
|
Sulfonamides | 1 | 2016 | 1977 | 0.070 |
Why?
|
Drug Therapy | 1 | 2010 | 504 | 0.070 |
Why?
|
Dioxygenases | 2 | 2020 | 335 | 0.070 |
Why?
|
Rabbits | 1 | 2013 | 4773 | 0.070 |
Why?
|
Osteoclasts | 2 | 2007 | 711 | 0.070 |
Why?
|
Algorithms | 3 | 2017 | 13981 | 0.070 |
Why?
|
Cell Lineage | 3 | 2023 | 2533 | 0.070 |
Why?
|
Crohn Disease | 1 | 2019 | 2275 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4354 | 0.070 |
Why?
|
Apyrase | 1 | 2008 | 373 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12965 | 0.060 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 936 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2012 | 1096 | 0.060 |
Why?
|
Alleles | 4 | 2019 | 6898 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2023 | 80372 | 0.060 |
Why?
|
Immunocompromised Host | 1 | 2010 | 857 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8552 | 0.060 |
Why?
|
Treatment Outcome | 10 | 2022 | 65017 | 0.060 |
Why?
|
Genome, Human | 1 | 2017 | 4417 | 0.060 |
Why?
|
Gamma Rays | 2 | 2002 | 317 | 0.060 |
Why?
|
Tumor Burden | 2 | 2008 | 1895 | 0.060 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2006 | 629 | 0.060 |
Why?
|
Mastectomy | 1 | 2012 | 1832 | 0.060 |
Why?
|
Science | 1 | 2006 | 239 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5508 | 0.060 |
Why?
|
Recurrence | 3 | 2023 | 8482 | 0.060 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2002 | 881 | 0.060 |
Why?
|
Meiosis | 2 | 2002 | 328 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3202 | 0.060 |
Why?
|
DNA Damage | 3 | 2021 | 2442 | 0.050 |
Why?
|
Random Allocation | 2 | 2019 | 2394 | 0.050 |
Why?
|
Models, Biological | 2 | 2017 | 9467 | 0.050 |
Why?
|
Bone Diseases | 1 | 2006 | 419 | 0.050 |
Why?
|
Young Adult | 8 | 2021 | 58741 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2019 | 17790 | 0.050 |
Why?
|
Haploidy | 1 | 2002 | 133 | 0.050 |
Why?
|
Procarbazine | 1 | 2022 | 172 | 0.050 |
Why?
|
Rad51 Recombinase | 1 | 2002 | 188 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6544 | 0.050 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2379 | 0.050 |
Why?
|
Hydrolysis | 1 | 2002 | 665 | 0.050 |
Why?
|
Mentors | 1 | 2006 | 661 | 0.050 |
Why?
|
Child, Preschool | 6 | 2021 | 42063 | 0.050 |
Why?
|
Chromosome Aberrations | 2 | 2021 | 1764 | 0.050 |
Why?
|
Catalysis | 1 | 2002 | 775 | 0.050 |
Why?
|
U937 Cells | 1 | 2021 | 262 | 0.050 |
Why?
|
Endodeoxyribonucleases | 1 | 2001 | 164 | 0.050 |
Why?
|
DNA Repair Enzymes | 1 | 2002 | 345 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10181 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2008 | 4902 | 0.040 |
Why?
|
Exodeoxyribonucleases | 1 | 2001 | 195 | 0.040 |
Why?
|
Plasmids | 2 | 2002 | 2275 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2017 | 5397 | 0.040 |
Why?
|
Remission Induction | 2 | 2018 | 2392 | 0.040 |
Why?
|
Child | 8 | 2021 | 79806 | 0.040 |
Why?
|
Molecular Biology | 1 | 2023 | 580 | 0.040 |
Why?
|
Radiotherapy | 1 | 2006 | 1504 | 0.040 |
Why?
|
Adolescent | 8 | 2021 | 87810 | 0.040 |
Why?
|
Genotype | 3 | 2017 | 12960 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 234 | 0.040 |
Why?
|
Cell Division | 2 | 2007 | 4463 | 0.040 |
Why?
|
K562 Cells | 1 | 2021 | 640 | 0.040 |
Why?
|
Survival Analysis | 3 | 2017 | 10182 | 0.040 |
Why?
|
Kidney | 1 | 2014 | 7064 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2021 | 18137 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9276 | 0.040 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2022 | 495 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Neoplasms | 2 | 2019 | 22072 | 0.040 |
Why?
|
Phthalazines | 1 | 2021 | 383 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 224 | 0.040 |
Why?
|
Skull Base | 1 | 2021 | 291 | 0.040 |
Why?
|
Digestive System | 1 | 2019 | 244 | 0.040 |
Why?
|
Phenotype | 4 | 2017 | 16546 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2018 | 155 | 0.040 |
Why?
|
Cell Death | 1 | 2023 | 1672 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 95 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2012 | 11152 | 0.040 |
Why?
|
Hemorrhage | 1 | 2009 | 3600 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2717 | 0.040 |
Why?
|
Hyperplasia | 1 | 2020 | 1155 | 0.040 |
Why?
|
Zygote | 1 | 2017 | 115 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2009 | 14372 | 0.040 |
Why?
|
Dogs | 1 | 2022 | 3841 | 0.040 |
Why?
|
DNA Helicases | 1 | 2002 | 854 | 0.040 |
Why?
|
Disease Management | 2 | 2019 | 2514 | 0.040 |
Why?
|
Age Factors | 3 | 2020 | 18416 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 231 | 0.030 |
Why?
|
Structure Collapse | 1 | 2016 | 4 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2021 | 9530 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2020 | 1600 | 0.030 |
Why?
|
Aspirin | 1 | 2008 | 3364 | 0.030 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 193 | 0.030 |
Why?
|
Genes, myc | 1 | 2017 | 395 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 635 | 0.030 |
Why?
|
Lung | 1 | 2014 | 9994 | 0.030 |
Why?
|
Receptors, Fc | 1 | 2019 | 534 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 698 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
Dacarbazine | 1 | 2018 | 560 | 0.030 |
Why?
|
Heterozygote | 1 | 2002 | 2798 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2023 | 2414 | 0.030 |
Why?
|
Models, Genetic | 2 | 2002 | 3442 | 0.030 |
Why?
|
STAT Transcription Factors | 1 | 2016 | 188 | 0.030 |
Why?
|
Doxorubicin | 1 | 2022 | 2209 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2017 | 653 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2008 | 3201 | 0.030 |
Why?
|
Cell Shape | 1 | 2016 | 372 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 542 | 0.030 |
Why?
|
Head | 1 | 2021 | 922 | 0.030 |
Why?
|
Africa South of the Sahara | 1 | 2017 | 742 | 0.030 |
Why?
|
Blotting, Western | 1 | 2002 | 5039 | 0.030 |
Why?
|
STAT1 Transcription Factor | 1 | 2016 | 333 | 0.030 |
Why?
|
Janus Kinases | 1 | 2016 | 250 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2019 | 424 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 852 | 0.030 |
Why?
|
Protein Binding | 2 | 2018 | 9335 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39261 | 0.030 |
Why?
|
Immune Evasion | 1 | 2018 | 362 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2017 | 468 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 353 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9501 | 0.030 |
Why?
|
Pericardial Effusion | 1 | 2016 | 247 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2016 | 388 | 0.030 |
Why?
|
Hepatitis, Autoimmune | 1 | 2016 | 172 | 0.030 |
Why?
|
Plasma Cells | 1 | 2017 | 591 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3301 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 713 | 0.030 |
Why?
|
Bone Density | 1 | 2006 | 3534 | 0.030 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 533 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2016 | 649 | 0.030 |
Why?
|
Hepatitis B Core Antigens | 1 | 2013 | 88 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2838 | 0.030 |
Why?
|
Osteosarcoma | 1 | 2019 | 897 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1007 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1347 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 830 | 0.030 |
Why?
|
Daunorubicin | 1 | 2012 | 156 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2018 | 1254 | 0.030 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2012 | 91 | 0.030 |
Why?
|
Ilium | 1 | 2012 | 154 | 0.020 |
Why?
|
Neural Conduction | 1 | 2013 | 441 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 2116 | 0.020 |
Why?
|
Polyploidy | 1 | 2012 | 119 | 0.020 |
Why?
|
Sternum | 1 | 2012 | 175 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 995 | 0.020 |
Why?
|
Diagnostic Imaging | 2 | 2021 | 3527 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2016 | 1832 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2017 | 10446 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2019 | 4810 | 0.020 |
Why?
|
Cytarabine | 1 | 2012 | 696 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1266 | 0.020 |
Why?
|
North America | 1 | 2014 | 1284 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22023 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1791 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5643 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2013 | 413 | 0.020 |
Why?
|
Signal Transduction | 3 | 2018 | 23376 | 0.020 |
Why?
|
Infant | 3 | 2017 | 36060 | 0.020 |
Why?
|
NF-kappa B | 1 | 2018 | 2488 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 41335 | 0.020 |
Why?
|
Chromatin | 1 | 2021 | 2938 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2014 | 1122 | 0.020 |
Why?
|
Risk Factors | 3 | 2020 | 74359 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9411 | 0.020 |
Why?
|
Chemokines, CXC | 1 | 2010 | 421 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2693 | 0.020 |
Why?
|
DNA | 1 | 2001 | 7233 | 0.020 |
Why?
|
Central Nervous System | 1 | 2015 | 1334 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2013 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5496 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3529 | 0.020 |
Why?
|
Kinetics | 2 | 2007 | 6377 | 0.020 |
Why?
|
Missouri | 1 | 2006 | 114 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10827 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5797 | 0.020 |
Why?
|
United States | 1 | 2014 | 72461 | 0.020 |
Why?
|
Financial Support | 1 | 2006 | 116 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1855 | 0.020 |
Why?
|
Benzylamines | 1 | 2006 | 248 | 0.020 |
Why?
|
Heterocyclic Compounds | 1 | 2006 | 247 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3568 | 0.020 |
Why?
|
Fever | 1 | 2013 | 1617 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2525 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6828 | 0.020 |
Why?
|
Developing Countries | 1 | 2017 | 2868 | 0.020 |
Why?
|
Budgets | 1 | 2006 | 230 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2008 | 562 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 2008 | 805 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12446 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2803 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12531 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7588 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3078 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2013 | 2272 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2016 | 3844 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13502 | 0.010 |
Why?
|
Time Factors | 2 | 2021 | 40165 | 0.010 |
Why?
|
Diphosphonates | 1 | 2007 | 638 | 0.010 |
Why?
|
Flap Endonucleases | 1 | 2001 | 17 | 0.010 |
Why?
|
Prostatic Neoplasms | 2 | 2019 | 11345 | 0.010 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2001 | 28 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15620 | 0.010 |
Why?
|
Suppression, Genetic | 1 | 2001 | 190 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 2006 | 1229 | 0.010 |
Why?
|
Neutropenia | 1 | 2006 | 884 | 0.010 |
Why?
|
Imidazoles | 1 | 2007 | 1180 | 0.010 |
Why?
|
Universities | 1 | 2006 | 992 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2882 | 0.010 |
Why?
|
Liver | 1 | 2016 | 7509 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15840 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
Bone Density Conservation Agents | 1 | 2007 | 796 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15789 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18957 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10344 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20080 | 0.010 |
Why?
|
Teaching | 1 | 2006 | 1169 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6465 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14660 | 0.010 |
Why?
|
Pain | 1 | 2013 | 5066 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 6216 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21392 | 0.010 |
Why?
|
Telomere | 1 | 2001 | 933 | 0.010 |
Why?
|
Cell Movement | 1 | 2006 | 5206 | 0.010 |
Why?
|
Neutrophils | 1 | 2006 | 3767 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26181 | 0.010 |
Why?
|
Biomedical Research | 1 | 2006 | 3426 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2006 | 4491 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8056 | 0.010 |
Why?
|